Advertisement
News
Subscribe to MDT Magazine News

Turbulent Times Ahead for Independent Imaging Facilities

March 18, 2011 7:35 am | by Diagnostic Imaging | Comments

The uncertainty of today's healthcare environment is just another hurdle in the daily operation of an imaging facility. How this and other challenges are handled will certainly determine the viability of your business.

TOPICS:

For Radiology Assistants: To Bill or Not to Bill?

March 18, 2011 7:35 am | by Diagnostic Imaging | Comments

Radiologist assistants (RAs) and radiology practitioner assistants (RPAs) may be highly educated and experienced, but CMS won't pay for their services in all settings. Reimbursement depends on the setting (office, hospital inpatient or outpatient, and independent diagnostic testing...

TOPICS:

ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor Human) in European Union

March 18, 2011 6:34 am | by Bio-Medicine.Org | Comments

EXTON, Pa., March 18, 2011 /- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a...

TOPICS:
Advertisement

Lilly and Avid Receive Complete Response Letter from FDA for Amyvidâ„¢ (florbetapir F 18 injection)

March 18, 2011 6:34 am | Comments

INDIANAPOLIS and PHILADELPHIA, March 18, 2011 /- Eli Lilly and Company (NYSE: LLY ) and its wholly owned subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter from the U.S. Food and Drug Administration (FDA) for their New Drug Application (NDA) for...

Celera 4Q profit drops as licensing revenue falls

March 18, 2011 5:45 am | by The Associated Press | Comments

Celera Corp. said Friday its fourth-quarter net income sank 31 percent, as the genetic diagnostics company saw drops in licensing and products revenue.The Alameda, Calif., company earned $2.5 million, or 3 cents per share, in the three months that ended Dec. 25. That compares with net income of...

New blood analysis chip could lead to disease diagnosis in minutes

March 18, 2011 5:39 am | by EurekAlert | Comments

(University of California - Berkeley) A major milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases within minutes. The device, developed by researchers at UC Berkeley, Dublin City University in Ireland and Universidad de...

TOPICS:

CooperVision Introduces New Corporate Brand Identity

March 18, 2011 5:36 am | by Bio-Medicine.Org | Comments

ROCHESTER, N.Y., March 18, 2011 /- Leading contact lens manufacturer, CooperVision today unveiled its new brand positioning and visual identity that better reflects the organization's values. (Logo: http://photos.prnewswire.com/prnh/20110318/NY67257LOGO) "CooperVision had a record year in...

TOPICS:

'2011 China-Africa Brightness Action' Launched in Beijing

March 18, 2011 5:36 am | by Bio-Medicine.Org | Comments

BEIJING, March 18, 2011 /PRNewswire-Asia/ -- The launching ceremony for the "2011 China-Africa Brightness Action" was held at the Beijing HNA Marriott Hotel on March 17th. Co-organized by the National Committee of Blindness Prevention (NCBP), China Association for Promoting Democracy, the...

TOPICS:
Advertisement

Quest Diagnostics to pay $671M for Celera Corp.

March 18, 2011 4:45 am | by The Associated Press | Comments

Medical laboratory operator Quest Diagnostics Inc. said Friday it will buy the diagnostics company Celera Corp. for $671 million in a deal that gives it access to proprietary genetic tests and a research and development pipeline focused on cardiovascular disease and cancer.Quest, which is...

China-Biotics Wins First US Customer

March 18, 2011 3:39 am | by Bio-Medicine.Org | Comments

SHANGHAI, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that the Company has entered into an agreement with a US...

TOPICS:

NIH Director Dr. Francis Collins to Present Keynote Address at Partnering for Global Health Forum 2011

March 18, 2011 3:35 am | by Biotechnology Industry Organization | Comments

WASHINGTON, D.C. (Wednesday, March 16, 2011) - The Biotechnology Industry Organization (BIO) and BIO Ventures for Global Health (BVGH) announced today that Francis Collins, MD, PhD, Director of the National Institutes of Health, will provide the keynote address at the Partnering for...

TOPICS:

A Look at 115-Year-Old X-Ray Equipment

March 18, 2011 3:35 am | by Diagnostic Imaging | Comments

X-ray equipment has become far more sophisticated in the last 115 years - and uses far lower radiation doses and exposure times, researchers found recently after testing a first-generation system from 1896.

TOPICS:

Radiation Safety Q & A: Can Decision Support Systems Help?

March 18, 2011 3:35 am | by Diagnostic Imaging | Comments

Stephen Herman, MD, an associate professor of radiology at University Health Network in Toronto, Ontario, Canada, and CEO of MedCurrent, discusses how radiology decision support systems can help reduce radiation exposure, and what it will take for the tools to catch on.

TOPICS:

Concord Medical to Report Fourth Quarter and Fiscal Year 2010 Financial Results on Monday, March 28, 2011

March 18, 2011 3:34 am | by Bio-Medicine.Org | Comments

BEIJING, March 18, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical") (NYSE: CCM ), operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will report its unaudited financial results...

TOPICS:

Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development

March 18, 2011 3:34 am | by Bio-Medicine.Org | Comments

MADISON, N.J. and ALAMEDA, Calif., March 18, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, and Celera Corporation (Nasdaq: CRA ), one of the world's pioneers in genetic diagnostics discovery and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading